To operate or not to operate: Clinical and sociodemographic determinants of provider advised non-surgical management for thyroid cancer
Authors:
Open Access
- 10 October 2026
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 262, 117292
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance EraJAMA Internal Medicine, 2025
- Thyroid CancerJAMA, 2024
- The Cost and Financial Burden of Thyroid Cancer on Patients in the USJAMA Otolaryngology–Head & Neck Surgery, 2022
- Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patientsHPB, 2022
- Too Much of a Good Thing? A Cautionary Tale of Thyroid Cancer Overdiagnosis and OvertreatmentThyroid®, 2020
- A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancerCancer, 2019
- Saving Thyroids — Overtreatment of Small Papillary CancersNew England Journal of Medicine, 2018
- Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active SurveillanceJAMA Otolaryngology–Head & Neck Surgery, 2017
- Current Thyroid Cancer Trends in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 2014
- An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese PatientsWorld Journal of Surgery, 2009